Gender-affirming hormone therapy: effects on cardiovascular risk and vascular function
Background: Gender-affirming hormone therapy (GAHT) is used in individuals with gender identity dysphoria to align their secondary sexual characteristics with their affirmed gender. We conducted a systematic review of the literature to explore the mechanisms regarding the effects of GAHT on the vasc...
Saved in:
Main Authors: | Kirsty A McGinley, Angela K Lucas-Herald, Paul Connelly, Christian Delles |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2025-01-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/14/2/EC-24-0222.xml |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations
by: Inder Sehgal
Published: (2023-07-01) -
Corrigendum: Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations
by: Inder Sehgal
Published: (2025-01-01) -
Association of the Effect of Alcohol Consumption on Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH), and Testosterone Hormones in Men: A Systematic Review and Meta-Analysis
by: Mahmood Moosazadeh, et al.
Published: (2024-12-01) -
‘Gender affirming healthcare’ is not what the family physician needs to know
by: Janet Giddy, et al.
Published: (2025-01-01) -
A Retrospective Study in Trans Individuals Undergoing Gender Affirming Testosterone Treatment: Can Changes in Prolactin Counteract the Negative Effects on the Lipid Profile?
by: Jojo Steininger, et al.
Published: (2024-12-01)